University Hospitals Southampton Foundation Trust
Southampton, Hampshire, SO16 6YD, United Kingdom
NCT Number: NCT06932224
This study aims to investigate the impact of hospitalisation on physical and cognitive performance in patients aged 65 and older admitted with an orthopaedic injury. This will be achieved by asking patients to participate in a series of physical and cognitive performance questionnaires and tests. These questionnaires and tests will be performed by the patients as close to their admission as possible and then again at day 7 of hospitalisation (or discharge if earlier) and at 4-6 weeks after discharge. However, if a patient's hospital stay lasts more than 30 days, they will be asked to take part in the interim data collection timepoint.
To summarize, patients will be assessed at least 3 times, 4 if your hospital stay is longer than 30 days. The first and second assessments will be in the hospital, and the third will be 4-6 weeks after discharge at you home (or where is appropriate). Additionally, patients will be asked to wear an activity watch between the first and second assessment.
The study will also explore patients experiences of their hospital stay and opinions on deconditioning, including the views and opinions of hospital staff. This information will be gathered by having interviews with a sample of the patients who took part in the questionnaires and tests and by having interviews with hospital staff. The interview will be conducted by the main researcher, Thomas Cartledge, and will take place either over the phone, online or in-person, depending on your preference. The interviews will be audio and/or video recorded, however the recordings will be deleted immediately once transcription is completed. The duration of the interview will last approximately 30-60 mins.
This study is active but is not currently recruiting participants.
Notify Me65 year and older
All sexes
Observational
Southampton, Hampshire, SO16 6YD, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Patient criteria:
Inclusion:
Exclusion:
Hospital staff criteria:
Inclusion:
Time frame: From enrolment to the last data collection point at 4-6 weeks post discharge
Time frame: From enrolment to the last data collection point at 4-6 weeks post discharge.
The specific measure used will be fat free mass (FFM)
Time frame: From enrolment to the last data collection point at 4-6 weeks post discharge.
Strength, assistance with walking, rising from a chair, climbing stairs, and falls (SARC-F) questionnaire.
Using a scale ranging from 0 to 10, with a higher score indicating a higher sarcopenia risk.
Time frame: 4-6 weeks (discharge to the final data collection point).
The SPPB score ranges from 0 to 12 points, with a higher score indicating better functional mobility.
Time frame: From enrolment to the last data collection point at 4-6 weeks post discharge.
The EuroQol-5D (EQ-5D) is a two part questionnaire. The first part is a descriptive system using five dimensions to describe health (mobility, self-care, usual activities, pain/discomfort and anxiety/depression).
The second part is a visual analogue scale (VAS) where participants indicate their overall health by drawing a line on a scale from 100 (best imaginable health) to 0 (worst imaginable health).
Time frame: From enrolment to the last data collection point at 4-6 weeks post discharge.
The original Barthel Index will be used, which uses a score ranging from 0 to 100. A higher score indicates a better physical function.
Time frame: From enrolment to the last data collection point at 4-6 weeks post discharge.
The MoCA score ranges from 0 to 30. A score of 26 or higher is generally considered normal, with lower scores indicating potential cognitive impairment.
Time frame: From enrolment to the last data collection point at 4-6 weeks post discharge.
The 4AT test is scored from 0-12. A score of 0 suggests no delirium and no moderate-severe cognitive impairment. A score from 1-3 suggests cognitive impairment but not delirium. A score of 4 or more suggest delirium.
Time frame: 3 months
Will see if patients are readmitted to hospital within 3 months. Information abstracted from medical records.
Time frame: 6 months
Will see if patients are readmitted to hospital within 6 months. Information abstracted from medical records.
Time frame: Time frame for patients will be their last hospital admission (approx 7 days long) and staff will be asked to recall information from their last 2 months of work.
Interviews will be conducted with older orthopaedic patients and hospital staff.
Time frame: Time frame for patients will be their last hospital admission (approx 7 days long) and staff will be asked to recall information from their last 2 months of work.
Interviews will be conducted with older orthopaedic patients and hospital staff.
Time frame: Time frame for patients will be their last hospital admission (approx 7 days long) and staff will be asked to recall information from their last 2 months of work.
Interviews will be conducted with older orthopaedic patients and hospital staff.
University of Southampton
Other
Hospital-associated Deconditioning: Exploring Factors Contributing to the Physical and Cognitive Decline of Older Adults During Hospitalisation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07710495
Behavior, Deconditioning
Guildford, Surrey, United Kingdom
View Trial DetailsNCT05492240
Aging, Deconditioning
Aurora, Colorado, United States
View Trial DetailsNCT07189975
Behavior, Deconditioning
Liège, Belgium
View Trial DetailsNCT06692478
Deconditioning, Hematopoietic Stem Cell Transplant
Phoenix, Arizona, United States
View Trial Details